Cargando…

Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is persistently threatening the lives of thousands of individuals globally. It triggers pulmonary oedema, driving to dyspnoea and lung failure. Viral infectivity of coronavirus disease 2019 (COVID‐19) is a genuine challenge due t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alahdal, Murad, Elkord, Eyad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393056/ https://www.ncbi.nlm.nih.gov/pubmed/35988156 http://dx.doi.org/10.1002/ctm2.1026

Ejemplares similares

Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
por: Meyiah, Abdo, et al.
Publicado: (2023)

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
por: Alahdal, Murad, et al.
Publicado: (2022)

Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
por: Alahdal, Murad, et al.
Publicado: (2023)

Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
por: Saleh, Reem, et al.
Publicado: (2020)

T‐cell responses and therapies against SARS‐CoV‐2 infection
por: Toor, Salman M., et al.
Publicado: (2020)

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
por: Gupta, Ishita, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients
por: Raghav, Alok, et al.
Publicado: (2021)

Thymus-Derived, Peripherally Derived, and in vitro-Induced T Regulatory Cells
por: Elkord, Eyad
Publicado: (2014)

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
por: Barberis, Elettra, et al.
Publicado: (2021)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(−) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans
por: Elkord, Eyad
Publicado: (2016)

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2
por: Taşlı, Neslihan Pakize, et al.
Publicado: (2022)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
por: Jo, Seri, et al.
Publicado: (2021)

SARS‐CoV‐2 infection in lung transplant recipients induces circulating exosomes with SARS‐CoV‐2 spike protein S2
por: Bansal, Sandhya, et al.
Publicado: (2021)

RNA interference as a promising treatment against SARS-CoV-2
por: Donia, Ahmed, et al.
Publicado: (2020)

Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment
por: Zhang, Zichen, et al.
Publicado: (2022)

Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses
por: Lam, Sin Man, et al.
Publicado: (2022)

A vaccine for SARS-CoV-2: goals and promises
Publicado: (2020)

MXenes show promise against SARS-CoV-2
por: Sealy, Cordelia
Publicado: (2021)

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)

Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12
por: Teng, Yun, et al.
Publicado: (2021)

SARS-CoV-2 infection and immune responses
por: Harne, Rakhi, et al.
Publicado: (2023)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

A review on Saudi Arabian wastewater treatment facilities and available disinfection methods: Implications to SARS-CoV-2 control
por: Alahdal, Hadil M., et al.
Publicado: (2021)

Mathematical model of SARS-CoV-2 immunity predicts Paxlovid rebound
por: Ranard, Benjamin L., et al.
Publicado: (2023)

Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
por: Akbari, Ali, et al.
Publicado: (2020)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

SARS-CoV-2 takes the bait: Exosomes as endogenous decoys
por: Fernbach, Sonja, et al.
Publicado: (2022)

Promising methods for detection of novel coronavirus SARS‐CoV‐2
por: Liu, Ran, et al.
Publicado: (2020)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
por: Truong, Thao T., et al.
Publicado: (2022)

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Assessing Immune Response to SARS-CoV-2 Infection
por: Shurin, Michael R, et al.
Publicado: (2020)

Persistent Cellular Immunity to SARS-CoV-2 Infection
por: Breton, Gaëlle, et al.
Publicado: (2020)

Immunity to SARS‐CoV‐2 induced by infection or vaccination
por: Castro Dopico, Xaquin, et al.
Publicado: (2021)

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

Role of the Immune Microenvironment in SARS-CoV-2 Infection
por: Ye, Chih-Hung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nkcmfips2gcdrknkvie5g9klfa